Aggamin is a startup based in the United States.
Aggamin is a biotechnology company developing an extracorporeal device to treat preeclampsia by reducing circulating pathogenic proteins, aiming to improve maternal and neonatal outcomes.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.